Galena Biopharma Inc news

   Watch this stock
Showing stories 1 - 10 of about 91   

Articles published

GALE 2.30 -0.06 (-2.54%)
price chart
Why Galena Biopharma Inc. Stock Tumbled
Although we don't believe in timing the market or panicking over market movements, we do like to keep an eye on big changes -- just in case they're material to our investing thesis.
Galena Biopharma Reports Second Quarter 2014 Results  CNNMoney
Galena Biopharma Stock Price Down 9.2% on Disappointing Earnings (GALE)  Ticker Report
Related articles »  
Earnings Reaction History: Galena Biopharma, Inc., 66.7% Follow-Through ...
Galena Biopharma, Inc. ( GALE ) is due to issue its quarterly earnings report in the upcoming extended-hours session.
Galena Biopharma Stock Rating Reaffirmed by Roth Capital (GALE)
Galena Biopharma Inc logo Roth Capital reissued their buy rating on shares of Galena Biopharma (NASDAQ:GALE) in a research report released on Thursday morning.
Investors Alert: Galena Biopharma (NASDAQ:GALE), Sky-mobi Limited ...  WallStreet Scope
Related articles »  
Biotech News Bundle: Galena Biopharma Inc (GALE), Aegerion ...
Galena Biopharma Inc (NASDAQ:GALE) climbed higher on Wednesday after MLV & Co analyst Vernon T. Bernardino reiterated a Buy rating on the stock.
Related articles »  
Galena Biopharma Appoints Mark W. Schwartz, Ph.D., as President and Chief ...
Galena Biopharma, Inc. GALE, -3.81% a biopharmaceutical company developing and commercializing innovative, targeted oncology treatments that address major medical needs across the full spectrum of cancer care, today announced that Mark W.
Galena Biopharma Inc.: Galena Biopharma Appoints Mark W. Schwartz, Ph.D ...  The Wall Street Transcript
Galena CEO gets the boot (GALE)  Seeking Alpha (registration)
Related articles »  
Top Gainers List: LiveDeal Inc (LIVE), Galena Biopharma (GALE), RadioShack ...
Galena Biopharma Inc (NASDAQ:GALE) jumped about 10 percent today after MLV & Co reaffirmed a �Buy� rating for the biotechnology company, in a research report sent to investors on 27th of August.
Galena Biopharma Given Positive Rating at MLV & Co (GALE)
Galena Biopharma, Inc (NASDAQ:GALE), formerly RXi Pharmaceuticals Corporation, incorporated on April 3, 2006, is a biotechnology company focused on discovering, developing and commercializing therapies addressing unmet medical needs using ...
Stocks Alert: Galena Biopharma, Inc. (NASDAQ:GALE), 22nd Century Group, Inc ...  Market News Call
Related articles »  
Market Movers: Galena Biopharma, Inc. (NASDAQ:GALE), Dominion Resources ...
On 11 AUG Galena Biopharma, Inc. (NASDAQ:GALE) last issued its quarterly earnings data on Monday. The company reported ($0.17) EPS for the quarter, missing the Thomson Reuters consensus estimate of ($0.09) by $0.08.
Top Wall Street Stories: Renren Inc. (NYSE:RENN), Galena Biopharma, Inc ...
On 11 AUG Galena Biopharma, Inc. (NASDAQ:GALE) last posted its quarterly earnings results on Monday. The company reported ($0.17) EPS for the quarter, missing the Thomson Reuters consensus estimate of ($0.09) by $0.08.
Galena Biopharma's Positive Rating Reiterated at MLV & Co (GALE)  Intercooler
Related articles »  
Stocks Alert � Hewlett-Packard Company (NYSE:HPQ), Galena Biopharma Inc ...
Hewlett-Packard Company (NYSE:HPQ) said Thursday it has signed an agreement with Beijing UnionRead Information Technology to build and operate community clouds for business customers in China.
Related articles »